Cara Therapeutics | Kortsiktig Gjeld

Current Liabilities Endring Dato
Acadia Pharmaceuticals USD 254.25M 44.65M 2023-12
Cassava Sciences USD 17.41M 481K 2023-09
Chugai Pharma JPY 264.12B 34.34B 2023-09
Clal Biotechnology ILS 2.91M 173K 2022-12
Compugen USD 10.38M 425K 2023-09
CSL USD 4.61B 278.2M 2023-06
Grifols EUR 2.03B 148.07M 2023-09
Halozyme Therapeutics USD 112.49M 2.69M 2023-12
Neurocrine Biosciences USD 691.6M 109.1M 2023-09
Pacira USD 97.38M 3.72M 2023-12
Pfizer USD 31.14B 3.51B 2023-09
RedHill Biopharma USD 28.19M 20.25M 2023-06
Supernus Pharmaceuticals USD 290.2M 2.66M 2023-12



Cara Therapeutics Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2024.